University research records
Northern Border University
4 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →4 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Northern Border University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–4 of 4 matching records. Counts update as records arrive.
Enhanced Outcomes of SGLT2 Inhibitors and GLP-1 Receptor Agonists: A Systematic Review of Major Adverse Cardiovascular Events and Renal Outcomes
June 10, 2026 · 0 citations · Open access
Open original record →Exploring the potential of SGLT2 inhibitors in Alzheimer’s disease: network pharmacology, molecular docking, and MD simulation study
March 16, 2026 · 2 citations · Open access
Open original record →Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
January 6, 2026 · 3 citations · Open access
Open original record →Advances and Future Directions in GLP-1 Receptor Agonist Therapy for Type 2 Diabetes: Efficacy, Safety and Cardiometabolic Benefits
January 1, 2026 · 0 citations · Open access
Open original record →
